Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice - Aix-Marseille Université Access content directly
Journal Articles Journal of Alzheimer's Disease Year : 2016

Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice

Abstract

Two tetrapeptides, HAEE and RADD, which are ionic-complementary to the primary zinc recognition site of amyloid-(A), have been reported to inhibit zinc-induced dimerization of the A metal-binding domain and slow A aggregation in vitro. In the present study, we investigate the impact of HAEE and RADD on the development of cerebral-amyloidosis in a mouse model of Alzheimer's disease. We have found chronic intravenous administration of each peptide results in significant decrease of amyloid plaque burden in the treated mice.
Fichier principal
Vignette du fichier
JAD150031(1).pdf (90.17 Ko) Télécharger le fichier
Origin : Explicit agreement for this submission

Dates and versions

hal-01478712 , version 1 (28-02-2017)

Identifiers

Cite

Philipp A Tsvetkov, Ivan B Cheglakov, Armen A Ovsepyan, Oleg O Mediannikov, Alexander A Morozov, et al.. Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice. Journal of Alzheimer's Disease, 2016, pp.20 - 20. ⟨10.3233/JAD-150031⟩. ⟨hal-01478712⟩

Collections

INSERM UNIV-AMU
79 View
364 Download

Altmetric

Share

Gmail Facebook X LinkedIn More